Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Shares Outstanding (2016 - 2026)

Sunshine Biopharma filings provide 14 years of Shares Outstanding readings, the most recent being $130000.0 for Q4 2025.

  • On a quarterly basis, Shares Outstanding fell 94.96% to $130000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $130000.0, a 94.96% decrease, with the full-year FY2025 number at $130000.0, down 94.96% from a year prior.
  • Shares Outstanding hit $4.9 million in Q4 2025 for Sunshine Biopharma, up from $4.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $18.9 million in Q2 2022 to a low of $10000.0 in Q3 2022.
  • Median Shares Outstanding over the past 5 years was $565000.0 (2021), compared with a mean of $2.6 million.
  • Biggest five-year swings in Shares Outstanding: tumbled 99.95% in 2023 and later skyrocketed 19896.6% in 2024.
  • Sunshine Biopharma's Shares Outstanding stood at $1.0 million in 2021, then tumbled by 98.87% to $11293.0 in 2022, then rose by 24.08% to $14012.0 in 2023, then soared by 18313.49% to $2.6 million in 2024, then tumbled by 94.96% to $130000.0 in 2025.
  • The last three reported values for Shares Outstanding were $130000.0 (Q4 2025), $4.6 million (Q3 2025), and $4.6 million (Q2 2025) per Business Quant data.